Bio-Reference Laboratories (BRLI) 34.63 $BRLI
Bio-Reference Labs Up 13.3% Since SmarTrend Uptrend Call (BRLI)
Comtex SmarTrend(R) - Fri Feb 13, 9:31AM CST
SmarTrend identified an Uptrend for Bio-Reference Labs (NASDAQ:BRLI) on December 22nd, 2014 at $30.54. In approximately 2 months, Bio-Reference Labs has returned 13.31% as of today's recent price of $34.60.
BRLI: 34.63 (+0.06)
Henry Schein (HSIC) Beats Q4 Earnings, Revenues in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:48AM CST
We are impressed with Henry Schein's (HSIC) fourth-quarter 2014 financial results which modestly beat the Zacks Consensus Estimate for EPS, while being in line with the same for revenues.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), HSIC: 143.18 (+0.72)
BioReference Laboratories, Inc. Hires Industry Veteran, Joseph F. Donahue, to Lead New Business Group
GlobeNewswire - Thu Feb 12, 7:30AM CST
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today the formation of a new business group -- the Commercial Collaborations and Innovations ("CCI"
Group. This new business group will be under the direction of newly appointed Senior Vice President, Joseph F. Donahue, and will focus on providing solutions that help accelerate pharmaceutical innovation, development and go to market activities.
BRLI: 34.63 (+0.06)
CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 4:40PM CST
With this agreement, CR Bard Inc. (BCR) intends to expand the reach of Lutonix DCB and allow more patients suffering from PAD to benefit from this innovative technology.
HYH: 44.50 (+0.52), BSX: 14.98 (+0.24), BCR: 175.38 (+0.50), BRLI: 34.63 (+0.06)
MWI Veterinary (MWIV) Beats on Q1 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:30AM CST
MWI Veterinary (MWIV) reports first-quarter fiscal 2015 results.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), MWIV: 189.72 (-0.17)
Invacare (IVC) Crumbles: Stock Falls by 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 7:50AM CST
Invacare's shares fell 6% on the day trading at a volatile range in the past one-month time frame, showed a sharp decline Friday at $16.82.
BRLI: 34.63 (+0.06), IVC: 17.13 (+0.15)
Bio-Reference Labs Has Returned 11.1% Since SmarTrend Recommendation (BRLI)
Comtex SmarTrend(R) - Thu Feb 05, 5:00PM CST
SmarTrend identified an Uptrend for Bio-Reference Labs (NASDAQ:BRLI) on December 22nd, 2014 at $30.54. In approximately 2 month, Bio-Reference Labs has returned 11.05% as of today's recent price of $33.91.
BRLI: 34.63 (+0.06)
Merit Medical Systems, Inc. (MMSI) Jumps: Stock Rises 9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 8:32AM CST
Merit Medical Systems, Inc. (MMSI) was a big mover last session, as the company saw its shares rise more than 9% on the day.
BRLI: 34.63 (+0.06), MMSI: 17.27 (-0.16)
STAAR Surgical (STAA) in Focus: Stock Moves 7.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 8:25AM CST
STAAR Surgical (STAA) was a big mover last session, with shares rising roughly 8% on the day.
BRLI: 34.63 (+0.06), STAA: 6.76 (-0.02)
How to Pick Winning Stocks When the Market is Going Down - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Feb 03, 12:00AM CST
How to Pick Winning Stocks When the Market is Going Down - Screen of the Week
ANW: 14.92 (+0.25), CTAS: 81.64 (-0.57), BRLI: 34.63 (+0.06), SCSS: 32.14 (+0.43), VMC: 79.87 (+0.46)
Align Misses Q4 Earnings by a Penny, Shares Tank 9.6% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:40AM CST
Align's (ALGN) earnings per share during the quarter remained close to the lower end of the company-provided guidance range of 47-50 cents, although the same missed the Zacks Consensus Estimate by a penny
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), ALGN: 56.90 (-0.34)
C.R. Bard Beats Q4 Earnings and Sales, 15' Outlook Cautious - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 2:00PM CST
C. R. Bard Inc (BCR) reported an impressive fourth quarter of 2014, wherein EPS of $2.29 surpassed the Zacks Consensus Estimate by a nickel.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BCR: 175.38 (+0.50), BRLI: 34.63 (+0.06)
PerkinElmer Beats Q4 Earnings & Revenues, View Optimistic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 12:20PM CST
PerkinElmer Inc (PKI) reported fourth-quarter 2014 EPS of 85 cents, which surpassed the Zacks Consensus Estimate by 7 cents.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), PKI: 46.30 (-0.10)
CONMED Q4 Earnings Flat but Revenues Down, '15 View Cut - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 11:20AM CST
CONMED Corporation (CNMD) posted adjusted earnings of 53 cents per share in the fourth quarter of 2014, which remained flat on a year-over-year basis.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), CNMD: 48.98 (+1.80)
Will Patterson Companies' Safety Measures Hold? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 19, 3:50PM CST
Distributor of dental, veterinary, and rehabilitation supplies, Patterson Companies, Inc. (PDCO) has declared that it is taking necessary initiatives in order to prevent unsafe dental products from entering the market.
HYH: 44.50 (+0.52), BRLI: 34.63 (+0.06), PDCO: 50.65 (-0.16), ATRS: 2.45 (+0.05)
Henry Schein Expands Dental Line in North America, Stock Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 1:30PM CST
Henry Schein's (HSIC) decision to distribute A-dec's products in North America reflects the former's commitment to expand its customers' access to the widest range of dental equipment.
HYH: 44.50 (+0.52), BRLI: 34.63 (+0.06), ATRS: 2.45 (+0.05), HSIC: 143.18 (+0.72)
Becton, Dickinson's Intelliport System Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 11:50AM CST
Following an approval from the federal agency, Becton, Dickinson and Company (BDX) aims to make the system commercially available starting spring 2015.
HYH: 44.50 (+0.52), BDX: 143.71 (+0.72), BRLI: 34.63 (+0.06), CFN: 59.81 (+0.01)
Halyard Health: A Strong Buy on Positive Estimate Revision - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 8:10AM CST
On Jan 7, 2015, Zacks Investment Research upgraded Halyard Health Inc (HYH) to a Zacks Rank #1 (Strong Buy).
HYH: 44.50 (+0.52), BRLI: 34.63 (+0.06), KMB: 111.00 (+0.82), SURG: 4.44 (-0.02)
Moving Average Crossover Alert: Bio-Reference Laboratories (BRLI) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 7:27AM CST
Moving Average Crossover Alert: Bio-Reference Laboratories (BRLI)
BRLI: 34.63 (+0.06)
Bio-Reference Labs Up 13.3% Since SmarTrend Uptrend Call (BRLI)
Comtex SmarTrend(R) - Fri Feb 13, 9:31AM CST
SmarTrend identified an Uptrend for Bio-Reference Labs (NASDAQ:BRLI) on December 22nd, 2014 at $30.54. In approximately 2 months, Bio-Reference Labs has returned 13.31% as of today's recent price of $34.60.
BRLI: 34.63 (+0.06)
Henry Schein (HSIC) Beats Q4 Earnings, Revenues in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:48AM CST
We are impressed with Henry Schein's (HSIC) fourth-quarter 2014 financial results which modestly beat the Zacks Consensus Estimate for EPS, while being in line with the same for revenues.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), HSIC: 143.18 (+0.72)
BioReference Laboratories, Inc. Hires Industry Veteran, Joseph F. Donahue, to Lead New Business Group
GlobeNewswire - Thu Feb 12, 7:30AM CST
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today the formation of a new business group -- the Commercial Collaborations and Innovations ("CCI"
Group. This new business group will be under the direction of newly appointed Senior Vice President, Joseph F. Donahue, and will focus on providing solutions that help accelerate pharmaceutical innovation, development and go to market activities. BRLI: 34.63 (+0.06)
CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 4:40PM CST
With this agreement, CR Bard Inc. (BCR) intends to expand the reach of Lutonix DCB and allow more patients suffering from PAD to benefit from this innovative technology.
HYH: 44.50 (+0.52), BSX: 14.98 (+0.24), BCR: 175.38 (+0.50), BRLI: 34.63 (+0.06)
MWI Veterinary (MWIV) Beats on Q1 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:30AM CST
MWI Veterinary (MWIV) reports first-quarter fiscal 2015 results.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), MWIV: 189.72 (-0.17)
Invacare (IVC) Crumbles: Stock Falls by 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 7:50AM CST
Invacare's shares fell 6% on the day trading at a volatile range in the past one-month time frame, showed a sharp decline Friday at $16.82.
BRLI: 34.63 (+0.06), IVC: 17.13 (+0.15)
Bio-Reference Labs Has Returned 11.1% Since SmarTrend Recommendation (BRLI)
Comtex SmarTrend(R) - Thu Feb 05, 5:00PM CST
SmarTrend identified an Uptrend for Bio-Reference Labs (NASDAQ:BRLI) on December 22nd, 2014 at $30.54. In approximately 2 month, Bio-Reference Labs has returned 11.05% as of today's recent price of $33.91.
BRLI: 34.63 (+0.06)
Merit Medical Systems, Inc. (MMSI) Jumps: Stock Rises 9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 8:32AM CST
Merit Medical Systems, Inc. (MMSI) was a big mover last session, as the company saw its shares rise more than 9% on the day.
BRLI: 34.63 (+0.06), MMSI: 17.27 (-0.16)
STAAR Surgical (STAA) in Focus: Stock Moves 7.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 8:25AM CST
STAAR Surgical (STAA) was a big mover last session, with shares rising roughly 8% on the day.
BRLI: 34.63 (+0.06), STAA: 6.76 (-0.02)
How to Pick Winning Stocks When the Market is Going Down - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Feb 03, 12:00AM CST
How to Pick Winning Stocks When the Market is Going Down - Screen of the Week
ANW: 14.92 (+0.25), CTAS: 81.64 (-0.57), BRLI: 34.63 (+0.06), SCSS: 32.14 (+0.43), VMC: 79.87 (+0.46)
Align Misses Q4 Earnings by a Penny, Shares Tank 9.6% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:40AM CST
Align's (ALGN) earnings per share during the quarter remained close to the lower end of the company-provided guidance range of 47-50 cents, although the same missed the Zacks Consensus Estimate by a penny
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), ALGN: 56.90 (-0.34)
C.R. Bard Beats Q4 Earnings and Sales, 15' Outlook Cautious - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 2:00PM CST
C. R. Bard Inc (BCR) reported an impressive fourth quarter of 2014, wherein EPS of $2.29 surpassed the Zacks Consensus Estimate by a nickel.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BCR: 175.38 (+0.50), BRLI: 34.63 (+0.06)
PerkinElmer Beats Q4 Earnings & Revenues, View Optimistic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 30, 12:20PM CST
PerkinElmer Inc (PKI) reported fourth-quarter 2014 EPS of 85 cents, which surpassed the Zacks Consensus Estimate by 7 cents.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), PKI: 46.30 (-0.10)
CONMED Q4 Earnings Flat but Revenues Down, '15 View Cut - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 11:20AM CST
CONMED Corporation (CNMD) posted adjusted earnings of 53 cents per share in the fourth quarter of 2014, which remained flat on a year-over-year basis.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), CNMD: 48.98 (+1.80)
Will Patterson Companies' Safety Measures Hold? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 19, 3:50PM CST
Distributor of dental, veterinary, and rehabilitation supplies, Patterson Companies, Inc. (PDCO) has declared that it is taking necessary initiatives in order to prevent unsafe dental products from entering the market.
HYH: 44.50 (+0.52), BRLI: 34.63 (+0.06), PDCO: 50.65 (-0.16), ATRS: 2.45 (+0.05)
Henry Schein Expands Dental Line in North America, Stock Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 1:30PM CST
Henry Schein's (HSIC) decision to distribute A-dec's products in North America reflects the former's commitment to expand its customers' access to the widest range of dental equipment.
HYH: 44.50 (+0.52), BRLI: 34.63 (+0.06), ATRS: 2.45 (+0.05), HSIC: 143.18 (+0.72)
Becton, Dickinson's Intelliport System Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 11:50AM CST
Following an approval from the federal agency, Becton, Dickinson and Company (BDX) aims to make the system commercially available starting spring 2015.
HYH: 44.50 (+0.52), BDX: 143.71 (+0.72), BRLI: 34.63 (+0.06), CFN: 59.81 (+0.01)
Halyard Health: A Strong Buy on Positive Estimate Revision - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 08, 8:10AM CST
On Jan 7, 2015, Zacks Investment Research upgraded Halyard Health Inc (HYH) to a Zacks Rank #1 (Strong Buy).
HYH: 44.50 (+0.52), BRLI: 34.63 (+0.06), KMB: 111.00 (+0.82), SURG: 4.44 (-0.02)
Moving Average Crossover Alert: Bio-Reference Laboratories (BRLI) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 7:27AM CST
Moving Average Crossover Alert: Bio-Reference Laboratories (BRLI)
BRLI: 34.63 (+0.06)
